{"id":55672,"date":"2023-04-11T14:04:37","date_gmt":"2023-04-11T12:04:37","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/boundless-bio-to-present-at-the-stifel-2023-virtual-targeted-oncology-days\/"},"modified":"2023-04-11T14:04:37","modified_gmt":"2023-04-11T12:04:37","slug":"boundless-bio-to-present-at-the-stifel-2023-virtual-targeted-oncology-days","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/boundless-bio-to-present-at-the-stifel-2023-virtual-targeted-oncology-days\/","title":{"rendered":"Boundless Bio to Present at the Stifel 2023 Virtual Targeted Oncology Days"},"content":{"rendered":"<div>\n<p>SAN DIEGO&#8211;(BUSINESS WIRE)&#8211;<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fboundlessbio.com%2F&amp;esheet=53378742&amp;newsitemid=20230411005177&amp;lan=en-US&amp;anchor=Boundless+Bio&amp;index=1&amp;md5=74091c0864164517800066ef63da37e9\" rel=\"nofollow noopener\" shape=\"rect\">Boundless Bio<\/a>, a next-generation precision oncology company developing innovative therapeutics directed against extrachromosomal DNA (ecDNA) in oncogene amplified cancers, today announced that its President and Chief Executive Officer, Zachary Hornby, will present at the Stifel 2023 Virtual Targeted Oncology Days event which will take place virtually. Presentation details are as follows:<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20230411005177\/en\/1059594\/5\/BB_Logo_orange_RGB_%281%29.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20230411005177\/en\/1059594\/21\/BB_Logo_orange_RGB_%281%29.jpg\"><\/a><\/p>\n<p>\nDate: Tuesday, April 25, 2023<br \/>\n<br \/>Time: 3:30 \u2013 3:55 PM ET<\/p>\n<p>\n<b>About Boundless Bio<\/b><\/p>\n<p>\nBoundless Bio is a next-generation precision oncology company dedicated to the discovery and development of new drugs targeting a novel area of cancer biology, extrachromosomal DNA (ecDNA), to deliver transformative therapies to patients with oncogene amplified cancers.<\/p>\n<p>\nFor more information, visit <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fboundlessbio.com%2F&amp;esheet=53378742&amp;newsitemid=20230411005177&amp;lan=en-US&amp;anchor=www.boundlessbio.com&amp;index=2&amp;md5=464c8cb45855bacf7e7cd485502885a7\" rel=\"nofollow noopener\" shape=\"rect\">www.boundlessbio.com<\/a>.<\/p>\n<p>\nFollow us on <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fboundlessbio%2F&amp;esheet=53378742&amp;newsitemid=20230411005177&amp;lan=en-US&amp;anchor=LinkedIn&amp;index=3&amp;md5=3f58de2182764d91188153c2ba689b65\" rel=\"nofollow noopener\" shape=\"rect\">LinkedIn<\/a> and <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Ftwitter.com%2FBoundlessBio%3Fs%3D20&amp;esheet=53378742&amp;newsitemid=20230411005177&amp;lan=en-US&amp;anchor=Twitter&amp;index=4&amp;md5=1723d80138f0f37b0fb9bf1efaa9be6b\" rel=\"nofollow noopener\" shape=\"rect\">Twitter<\/a>.<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nJames Lee<br \/>\n<br \/>Director of Business Development<br \/>\n<br \/>Boundless Bio<br \/>\n<br \/><a target=\"_blank\" href=\"&#x6d;&#x61;&#105;lt&#x6f;&#x3a;&#106;&#108;e&#x65;&#x40;&#98;&#111;u&#x6e;&#x64;&#x6c;&#101;ss&#x62;&#x69;&#111;&#46;c&#x6f;&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">&#x6a;&#x6c;&#101;e&#64;&#x62;&#x6f;&#117;&#110;d&#x6c;&#x65;&#115;&#115;b&#x69;&#x6f;&#x2e;&#99;om<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>SAN DIEGO&#8211;(BUSINESS WIRE)&#8211;Boundless Bio, a next-generation precision oncology company developing innovative therapeutics directed against extrachromosomal DNA (ecDNA) in oncogene amplified cancers, today announced that its President and Chief Executive Officer, Zachary Hornby, will present at the Stifel 2023 Virtual Targeted Oncology Days event which will take place virtually. Presentation details are as follows: Date: Tuesday, &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/boundless-bio-to-present-at-the-stifel-2023-virtual-targeted-oncology-days\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-55672","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Boundless Bio to Present at the Stifel 2023 Virtual Targeted Oncology Days - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/boundless-bio-to-present-at-the-stifel-2023-virtual-targeted-oncology-days\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Boundless Bio to Present at the Stifel 2023 Virtual Targeted Oncology Days - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"SAN DIEGO&#8211;(BUSINESS WIRE)&#8211;Boundless Bio, a next-generation precision oncology company developing innovative therapeutics directed against extrachromosomal DNA (ecDNA) in oncogene amplified cancers, today announced that its President and Chief Executive Officer, Zachary Hornby, will present at the Stifel 2023 Virtual Targeted Oncology Days event which will take place virtually. Presentation details are as follows: Date: Tuesday, ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/boundless-bio-to-present-at-the-stifel-2023-virtual-targeted-oncology-days\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-04-11T12:04:37+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230411005177\/en\/1059594\/21\/BB_Logo_orange_RGB_%281%29.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/boundless-bio-to-present-at-the-stifel-2023-virtual-targeted-oncology-days\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/boundless-bio-to-present-at-the-stifel-2023-virtual-targeted-oncology-days\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Boundless Bio to Present at the Stifel 2023 Virtual Targeted Oncology Days\",\"datePublished\":\"2023-04-11T12:04:37+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/boundless-bio-to-present-at-the-stifel-2023-virtual-targeted-oncology-days\\\/\"},\"wordCount\":136,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/boundless-bio-to-present-at-the-stifel-2023-virtual-targeted-oncology-days\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230411005177\\\/en\\\/1059594\\\/21\\\/BB_Logo_orange_RGB_%281%29.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/boundless-bio-to-present-at-the-stifel-2023-virtual-targeted-oncology-days\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/boundless-bio-to-present-at-the-stifel-2023-virtual-targeted-oncology-days\\\/\",\"name\":\"Boundless Bio to Present at the Stifel 2023 Virtual Targeted Oncology Days - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/boundless-bio-to-present-at-the-stifel-2023-virtual-targeted-oncology-days\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/boundless-bio-to-present-at-the-stifel-2023-virtual-targeted-oncology-days\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230411005177\\\/en\\\/1059594\\\/21\\\/BB_Logo_orange_RGB_%281%29.jpg\",\"datePublished\":\"2023-04-11T12:04:37+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/boundless-bio-to-present-at-the-stifel-2023-virtual-targeted-oncology-days\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/boundless-bio-to-present-at-the-stifel-2023-virtual-targeted-oncology-days\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/boundless-bio-to-present-at-the-stifel-2023-virtual-targeted-oncology-days\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230411005177\\\/en\\\/1059594\\\/21\\\/BB_Logo_orange_RGB_%281%29.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230411005177\\\/en\\\/1059594\\\/21\\\/BB_Logo_orange_RGB_%281%29.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/boundless-bio-to-present-at-the-stifel-2023-virtual-targeted-oncology-days\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Boundless Bio to Present at the Stifel 2023 Virtual Targeted Oncology Days\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Boundless Bio to Present at the Stifel 2023 Virtual Targeted Oncology Days - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/boundless-bio-to-present-at-the-stifel-2023-virtual-targeted-oncology-days\/","og_locale":"en_US","og_type":"article","og_title":"Boundless Bio to Present at the Stifel 2023 Virtual Targeted Oncology Days - Pharma Trend","og_description":"SAN DIEGO&#8211;(BUSINESS WIRE)&#8211;Boundless Bio, a next-generation precision oncology company developing innovative therapeutics directed against extrachromosomal DNA (ecDNA) in oncogene amplified cancers, today announced that its President and Chief Executive Officer, Zachary Hornby, will present at the Stifel 2023 Virtual Targeted Oncology Days event which will take place virtually. Presentation details are as follows: Date: Tuesday, ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/boundless-bio-to-present-at-the-stifel-2023-virtual-targeted-oncology-days\/","og_site_name":"Pharma Trend","article_published_time":"2023-04-11T12:04:37+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230411005177\/en\/1059594\/21\/BB_Logo_orange_RGB_%281%29.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/boundless-bio-to-present-at-the-stifel-2023-virtual-targeted-oncology-days\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/boundless-bio-to-present-at-the-stifel-2023-virtual-targeted-oncology-days\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Boundless Bio to Present at the Stifel 2023 Virtual Targeted Oncology Days","datePublished":"2023-04-11T12:04:37+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/boundless-bio-to-present-at-the-stifel-2023-virtual-targeted-oncology-days\/"},"wordCount":136,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/boundless-bio-to-present-at-the-stifel-2023-virtual-targeted-oncology-days\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230411005177\/en\/1059594\/21\/BB_Logo_orange_RGB_%281%29.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/boundless-bio-to-present-at-the-stifel-2023-virtual-targeted-oncology-days\/","url":"https:\/\/pharma-trend.com\/en\/boundless-bio-to-present-at-the-stifel-2023-virtual-targeted-oncology-days\/","name":"Boundless Bio to Present at the Stifel 2023 Virtual Targeted Oncology Days - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/boundless-bio-to-present-at-the-stifel-2023-virtual-targeted-oncology-days\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/boundless-bio-to-present-at-the-stifel-2023-virtual-targeted-oncology-days\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230411005177\/en\/1059594\/21\/BB_Logo_orange_RGB_%281%29.jpg","datePublished":"2023-04-11T12:04:37+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/boundless-bio-to-present-at-the-stifel-2023-virtual-targeted-oncology-days\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/boundless-bio-to-present-at-the-stifel-2023-virtual-targeted-oncology-days\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/boundless-bio-to-present-at-the-stifel-2023-virtual-targeted-oncology-days\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230411005177\/en\/1059594\/21\/BB_Logo_orange_RGB_%281%29.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230411005177\/en\/1059594\/21\/BB_Logo_orange_RGB_%281%29.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/boundless-bio-to-present-at-the-stifel-2023-virtual-targeted-oncology-days\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Boundless Bio to Present at the Stifel 2023 Virtual Targeted Oncology Days"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/55672","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=55672"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/55672\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=55672"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=55672"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=55672"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}